Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed and dated informed consent obtained before any trial-related activities~* Type 1 diabetes diagnosed and classified according to aetiology~* Duration of type 1 diabetes equal to or more than 12 months~* Glycosylated haemoglobin less than or equal to 12 percent based on analysis from central laboratory~* Able and willing to perform self-blood glucose monitoring~Exclusion Criteria:~* Proliferative retinopathy~* Total basal insulin dose of more than 100 IU per day~* Recurrent major hypoglycaemia - that would interfere with trial participation (as judged by the investigator)~* Known unawareness of hypoglycaemia~* Previous treatment with insulin detemir

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Insulin detemir (Type: EXPERIMENTAL): None
- NPH insulin (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).